Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001140361-16-091273

Director acquired 17,204 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KIRK RANDAL J Director 2016-12-30 Grant or award +17,204 139,513 D
Derivatives
KIRK RANDAL J Director 2016-12-30 Other acquisition · Series 1 Preferred Stock +1,051 106,184 I
Loading xslF345X03/doc1.xml…